Back to Search

A Phase III Study Comparing the Efficacy of the Combination of Doxorubicin and the Tumor-targeting Human Antibody-cytokine Fusion Protein L19TNF to Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma

  • Protocol Number: 201904129
  • Principal Investigator: Weiss, Mia
  • Cancer Types: Sarcoma

For more information on this trial, contact us here:

[email protected]

Brief Summary

Protocol Interventions